Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response
Titel:
Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response
Auteur:
Hesketh, P. J. Grunberg, S. M. Herrstedt, J. Wit, R. de Gralla, R. J. Carides, A. D. Taylor, A. Evans, J. K. Horgan, K. J.